US2020283632A1PendingUtilityA1
Process for preparing indigo carmine
Est. expiryDec 1, 2036(~10.4 yrs left)· nominal 20-yr term from priority
C09B 67/0096A23L 5/47C09B 7/08C09B 7/02C07D 403/04A61K 49/00A23V 2002/00A61K 47/22
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Process for preparing disodium 5,5′-indigosulfonate, the feedstock being indigo, this process including the following steps: i) the indigo is subjected to a sulfonation treatment resulting in a mixture that contains 5,5′-indigosulfonic acid, this process including: ii) a reduction treatment is applied to the mixture obtained in step i), and optionally a purification step, so as to obtain a composition including leuco-5,5′-indigosulfonic acid, iii) the leuco-5,5′-indigosulfonic acid is isolated from the composition resulting from step ii), iv) the leuco-5,5′-indigosulfonic acid resulting from step iii) is oxidized to give disodium 5,5′-indigosulfonate.
Claims
exact text as granted — not AI-modified1 . A composition comprising at least 99.5% of disodium 5,5′-indigosulfonate, the percentage being measured by high-pressure liquid chromatography with detection at 290 nm.
2 . The composition as claimed in claim 1 comprising at least 99.7% of disodium 5,5′-indigosulfonate, the percentage being measured by high-pressure liquid chromatography with detection at 290 nm.
3 . The composition as claimed in claim 1 in which no impurity is present in an amount of greater than 0.10%, the percentage being measured by high-pressure liquid chromatography with detection at 290 nm.
4 . The composition as claimed in claim 3 in which no impurity is present in an amount of greater than 0.05%, the percentage being measured by high-pressure liquid chromatography with detection at 290 nm.
5 . A medicament or a diagnostic product comprising the composition as claimed in claim 1 and a pharmaceutically acceptable support.
6 . The medicament or diagnostic product as claimed in claim 5 , which is in the form of a tablet or a gel capsule comprising from 1 to 1000 mg of the disodium 5,5′-indigosulfonate.
7 . The medicament or diagnostic product as claimed in claim 5 , which is in the form of an aqueous solution comprising the disodium 5,5′-indigosulfonate in a concentration ranging from 0.1% to 10% by mass.
8 . A food composition comprising the composition as claimed in claim 1 and a support that is compatible with a food application.
9 . The food composition as claimed in claim 8 , which is in powder form.
10 . The food composition as claimed in claim 8 , which is in aqueous solution form.
11 . The composition as claimed in claim 1 , wherein the disodium 5,5′-indigosulfonate is obtained by a process comprising the following steps, the starting material being indigo:
i) indigo is subjected to a sulfonation treatment leading to a mixture which contains 5,5′-indigosulfonic acid,
ii) the mixture obtained in step i) is subjected to a reduction treatment, and optionally a purification step, so as to obtain a composition comprising leuco-5,5′-indigosulfonic acid,
iii) the leuco-5,5′-indigosulfonic acid is isolated from the composition derived from step ii), and
iv) the leuco-5,5′-indigosulfonic acid obtained from step iii) is oxidized to disodium 5,5′-indigosulfonate.
12 . The composition as claimed in claim 11 , in which the reduction treatment of step ii) is performed using sodium dithionite in aqueous medium.
13 . The composition as claimed in claim 11 , in which the leuco-5,5′-indigosulfonic acid precipitates in the reaction medium on conclusion of step ii).
14 . The composition as claimed in claim 11 , in which step iii) includes the steps of:
iiia) filtration of the composition obtained from step ii), and iiib) recovery of the solid retained on the filter.
15 . The composition as claimed in claim 14 , in which step iii) also includes, after step iiib), at least one step iiic) consisting of washing the solid with an aqueous medium.
16 . The composition as claimed in claim 15 , in which step iiic) is applied from one to five times.
17 . The composition as claimed in claim 11 , in which the composition obtained on conclusion of step iii) includes at least 90 mol % of leuco-5,5′-indigosulfonic acid relative to the total number of moles of the composition.
18 . The composition as claimed in claim 11 , in which step iv) includes at least one step iva) consisting of a treatment with a base in alcoholic medium in the presence of an oxidizing agent.
19 . The composition as claimed in claim 18 , in which step iva) consists of a treatment with sodium ethoxide in ethanol, in the presence of an oxidizing agent.
20 . The composition as claimed in claim 18 , in which the oxidizing agent is gaseous oxygen.
21 . The composition as claimed in claim 18 , which also includes, after step iva), at least one step ivb) consisting of one or more washes with one or more alcoholic and/or aqueous-alcoholic solvents.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.